1. Home
  2. RRC vs BIO Comparison

RRC vs BIO Comparison

Compare RRC & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Range Resources Corporation

RRC

Range Resources Corporation

HOLD

Current Price

$43.43

Market Cap

8.2B

Sector

Energy

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$269.50

Market Cap

7.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RRC
BIO
Founded
1976
1952
Country
United States
United States
Employees
N/A
7450
Industry
Oil & Gas Production
Biotechnology: Laboratory Analytical Instruments
Sector
Energy
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
7.1B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
RRC
BIO
Price
$43.43
$269.50
Analyst Decision
Hold
Strong Buy
Analyst Count
16
4
Target Price
$41.94
$358.50
AVG Volume (30 Days)
3.1M
241.0K
Earning Date
05-25-2026
01-01-0001
Dividend Yield
0.91%
N/A
EPS Growth
151.38
N/A
EPS
2.74
N/A
Revenue
$3,115,515,000.00
N/A
Revenue This Year
$10.34
$2.51
Revenue Next Year
$8.73
$3.17
P/E Ratio
$16.03
$9.72
Revenue Growth
28.90
N/A
52 Week Low
$30.32
$211.43
52 Week High
$44.56
$343.12

Technical Indicators

Market Signals
Indicator
RRC
BIO
Relative Strength Index (RSI) 70.10 43.72
Support Level $33.88 $266.71
Resistance Level $43.50 $289.61
Average True Range (ATR) 1.39 7.99
MACD 0.15 0.10
Stochastic Oscillator 82.27 35.33

Price Performance

Historical Comparison
RRC
BIO

About RRC Range Resources Corporation

Fort Worth-based Range Resources is an independent exploration and production company with that focuses entirely on its operations in the Marcellus Shale in Pennsylvania. At year-end 2024, Range Resources' proven reserves totaled 18.1 trillion cubic feet equivalent, with net production of 2.2 billion cubic feet equivalent per day. Natural gas accounted for 68% of production.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: